OptimizeRx (OPRX) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist

4.830
-0.080-1.63%

Close Dec 23 16:00 ET

4.830
0.0000.00%

Post 20:01 ET

88.97MMarket Cap-3.60P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

JMP Securities Maintains OptimizeRx(OPRX.US) With Buy Rating, Maintains Target Price $8
Moomoo News14:31 ET · Ratings
Optimistic Buy Rating for OptimizeRx Amid Leadership Transition and Strong Financial Outlook
TipRanks13:35 ET · Ratings
OptimizeRx Names Stephen Silverstro as Interim CEO, Sees FY24 Revenue At High End of Guidance Range
MT NewswiresDec 23 09:31 ET
Express News | OptimizeRx Corp: Reaffirms Its Financial Guidance for Full Year 2024
ReutersDec 23 08:45 ET
Press Release: OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
Dow JonesDec 23 08:45 ET
Express News | OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
ReutersDec 23 08:45 ET

Comments

MARKET-TEST-DUMMY

Dec 7 07:49

👀

$OptimizeRx (OPRX.US)$

Jaguar8

Sep 10 07:09

NEWS

$OptimizeRx (OPRX.US)$
OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value
OptimizeRx Corp. (Nasdaq: OPRX) has expanded its strategic relationship with a major pharma client, resulting in a multi-solution, multi-brand program with a total in-year commitment of over $10 million. This includes the previously mentioned $6 million DAAP contract, which is still undergoing ...

Moomoo AI

Mar 15 07:14

Recent insider selling at OptimizeRx, especially by Marion Odence-Ford, may worry potential investors. The absence of insider buying and insignificant share ownership by insiders hint at possible doubts about future performance.

OptimizeRx's Stock Sinks To US$12.92, But Insiders Sold Even Lower

Moomoo AI

Dec 21, 2023 06:04

OptimizeRx's high P/S ratio may suggest that investors anticipate a turnaround in the company's revenue performance. This could indicate shareholders' strong future revenue expectations.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Moomoo AI

Dec 21, 2023 06:01

The high P/S ratio at OptimizeRx suggests investors expect a reversal of the company's downtrend in revenue. Shareholders seem to hold stocks with hope for the company's promising future.

Investors Appear Satisfied With OptimizeRx Corporation's (NASDAQ:OPRX) Prospects As Shares Rocket 40%

Heat List

Overall

No Data